ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,664 | +56.7% | 135 | +77.6% | 0.00% | 0.0% |
| Q2 2023 | $2,338 | +131.5% | 76 | +171.4% | 0.00% | – |
| Q1 2023 | $1,010 | -70.3% | 28 | -67.4% | 0.00% | -100.0% |
| Q4 2022 | $3,399 | +13.3% | 86 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | -25.0% | 86 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | +33.3% | 86 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | 0.0% | 86 | +14.7% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | – | 75 | +1400.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 5 | -82.8% | 0.00% | – |
| Q2 2021 | $1,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |